Major Depressive Disorder

DBS for Depression

Natural History of Depression, Bipolar Disorder and Suicide Risk

Predictors of Treatment Outcome in Major Depressive Disorder

Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder

Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback

Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

Closed-loop Optimized rTMS for Depression

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

JAK Signaling in Depression

Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS)

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

DBS for TRD With the Medtronic Percept PC

Intradermal Acupuncture as an Adjunct to SSRI Tapering in Major Depressive Disorder

Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Mobile Screening for Major Depressive Disorder in Adults From an Ethnically and Socioeconomically Diverse Population.

A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder

Individualized dlPFC-NAcc Modulation for Anhedonia in adMDD